» Articles » PMID: 32567746

Prevalence of PD-L1 Expression in Head and Neck Squamous Precancerous Lesions: a Systematic Review and Meta-analysis

Overview
Journal Head Neck
Date 2020 Jun 23
PMID 32567746
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Studies concerning programmed death-ligand 1 (PD-L1) expression in precancerous lesions of head and neck (HN) region have shown variable results.

Methods: We systematically reviewed the published evidence on PD-L1 expression in HN precancerous lesions.

Results: Of 1058 original articles, 14 were included in systematic review and 9 in meta-analysis. The pooled estimate of PD-L1 expression was 48.25% (confidence interval [CI] 21.07-75.98, I 98%, tau2 0.18). PD-L1 expression appeared to be more frequent in precancerous lesions than in normal mucosa (risk ratio [RR] 1.65, CI 0.65-4.03, I 91%, tau2 0.82) and less frequent than in invasive squamous cell carcinoma (RR 0.68, CI 0.43-1.08, I 91%, tau2 0.22).

Conclusions: PD-L1 expression could reflect a point of balance between host immune response and cancer escape ability. High heterogeneity and moderate quality suggest that further studies with larger sample size and more rigorous case selection will allow more precise assessment of PD-L1 expression in HN precancerous lesions.

Citing Articles

link to poor prognosis and immune infiltration of head and neck squamous cell carcinomas.

Zhang C, Ke J, Li J, Cai Q Transl Cancer Res. 2024; 13(11):6057-6069.

PMID: 39697720 PMC: 11651734. DOI: 10.21037/tcr-24-862.


The Potential of Oncolytic Virotherapy in the Treatment of Head and Neck Cancer: A Comprehensive Review.

Spirito F, Nocini R, Mori G, Albanese M, Georgakopoulou E, Sivaramakrishnan G Int J Mol Sci. 2024; 25(23).

PMID: 39684701 PMC: 11641702. DOI: 10.3390/ijms252312990.


Comparative analysis of PDL1 and cluster of differentiation 68 marker expression in oral squamous cell carcinoma patients: Correlation with depth of invasion and immunofluorescence through immunohistochemistry.

Shahabinejad M, Bagheri Shirvan S, Fatemi G, Mohajer Tehran F Dent Res J (Isfahan). 2024; 21:48.

PMID: 39376261 PMC: 11457987.


Clinicopathologic characteristics of HPV-associated head and neck squamous cell carcinoma in Southern China: long-term retrospective study of 400 cases.

Du M, Lin Q, Yan S, Gao X, Yang C, Li Z Ther Adv Med Oncol. 2024; 16:17588359241242962.

PMID: 38617023 PMC: 11010741. DOI: 10.1177/17588359241242962.


Efficacy and Safety of Nimotuzumab in Combination with Radiotherapy or Chemoradiotherapy for Local Advanced Head and Neck Cancer: A Systematic Review and Meta-analysis.

Zheng B, He M, Han Y, Jiang X, Ou X, Zhang P Curr Cancer Drug Targets. 2024; 24(9):952-966.

PMID: 38549541 DOI: 10.2174/0115680096281982240117114819.